Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Molecular Partners
Biotech
Amgen opts to DARP-out after seeing Molecular Partners data
After a peak at the earliest data for Molecular Partners’ DARPin therapy, Amgen is saying thanks but no thanks on the $550 million partnership.
Annalee Armstrong
Apr 26, 2022 4:38pm
Novartis splashes cash on COVID-19 antiviral, plans FDA filing
Jan 10, 2022 4:48am
JPM22, Day 1: Bayer strikes a Mammoth deal and more
Jan 10, 2022 4:25am
Novartis tags Molecular Partners for $580M radioligand deal
Dec 14, 2021 10:34am
Novartis-partnered DARPin flames out in COVID-19 study
Nov 16, 2021 8:15am
AbbVie snaps collab, license on Molecular Partners eye drug
Aug 9, 2021 9:22am